Dominik A Moser1, Gaelle E Doucet1, Won Hee Lee1, Alexander Rasgon1, Hannah Krinsky1, Evan Leibu1, Alex Ing2, Gunter Schumann2, Natalie Rasgon3,4, Sophia Frangou1. 1. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York. 2. Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom. 3. Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California. 4. Center for Neuroscience in Women's Health, Stanford University, Palo Alto, California.
Abstract
Importance: Alterations in multiple neuroimaging phenotypes have been reported in psychotic disorders. However, neuroimaging measures can be influenced by factors that are not directly related to psychosis and may confound the interpretation of case-control differences. Therefore, a detailed characterization of the contribution of these factors to neuroimaging phenotypes in psychosis is warranted. Objective: To quantify the association between neuroimaging measures and behavioral, health, and demographic variables in psychosis using an integrated multivariate approach. Design, Setting, and Participants: This imaging study was conducted at a university research hospital from June 26, 2014, to March 9, 2017. High-resolution multimodal magnetic resonance imaging data were obtained from 100 patients with schizophrenia, 40 patients with bipolar disorder, and 50 healthy volunteers; computed were cortical thickness, subcortical volumes, white matter fractional anisotropy, task-related brain activation (during working memory and emotional recognition), and resting-state functional connectivity. Ascertained in all participants were nonimaging measures pertaining to clinical features, cognition, substance use, psychological trauma, physical activity, and body mass index. The association between imaging and nonimaging measures was modeled using sparse canonical correlation analysis with robust reliability testing. Main Outcomes and Measures: Multivariate patterns of the association between nonimaging and neuroimaging measures in patients with psychosis and healthy volunteers. Results: The analyses were performed in 92 patients with schizophrenia (23 female [25.0%]; mean [SD] age, 27.0 [7.6] years), 37 patients with bipolar disorder (12 female [32.4%]; mean [SD] age, 27.5 [8.1] years), and 48 healthy volunteers (20 female [41.7%]; mean [SD] age, 29.8 [8.5] years). The imaging and nonimaging data sets showed significant covariation (r = 0.63, P < .001), which was independent of diagnosis. Among the nonimaging variables examined, age (r = -0.53), IQ (r = 0.36), and body mass index (r = -0.25) were associated with multiple imaging phenotypes; cannabis use (r = 0.23) and other substance use (r = 0.33) were associated with subcortical volumes, and alcohol use was associated with white matter integrity (r = -0.15). Within the multivariate models, positive symptoms retained associations with the global neuroimaging (r = -0.13), the cortical thickness (r = -0.22), and the task-related activation variates (r = -0.18); negative symptoms were mostly associated with measures of subcortical volume (r = 0.23), and depression/anxiety was associated with measures of white matter integrity (r = 0.12). Conclusions and Relevance: Multivariate analyses provide a more accurate characterization of the association between brain alterations and psychosis because they enable the modeling of other key factors that influence neuroimaging phenotypes.
Importance: Alterations in multiple neuroimaging phenotypes have been reported in psychotic disorders. However, neuroimaging measures can be influenced by factors that are not directly related to psychosis and may confound the interpretation of case-control differences. Therefore, a detailed characterization of the contribution of these factors to neuroimaging phenotypes in psychosis is warranted. Objective: To quantify the association between neuroimaging measures and behavioral, health, and demographic variables in psychosis using an integrated multivariate approach. Design, Setting, and Participants: This imaging study was conducted at a university research hospital from June 26, 2014, to March 9, 2017. High-resolution multimodal magnetic resonance imaging data were obtained from 100 patients with schizophrenia, 40 patients with bipolar disorder, and 50 healthy volunteers; computed were cortical thickness, subcortical volumes, white matter fractional anisotropy, task-related brain activation (during working memory and emotional recognition), and resting-state functional connectivity. Ascertained in all participants were nonimaging measures pertaining to clinical features, cognition, substance use, psychological trauma, physical activity, and body mass index. The association between imaging and nonimaging measures was modeled using sparse canonical correlation analysis with robust reliability testing. Main Outcomes and Measures: Multivariate patterns of the association between nonimaging and neuroimaging measures in patients with psychosis and healthy volunteers. Results: The analyses were performed in 92 patients with schizophrenia (23 female [25.0%]; mean [SD] age, 27.0 [7.6] years), 37 patients with bipolar disorder (12 female [32.4%]; mean [SD] age, 27.5 [8.1] years), and 48 healthy volunteers (20 female [41.7%]; mean [SD] age, 29.8 [8.5] years). The imaging and nonimaging data sets showed significant covariation (r = 0.63, P < .001), which was independent of diagnosis. Among the nonimaging variables examined, age (r = -0.53), IQ (r = 0.36), and body mass index (r = -0.25) were associated with multiple imaging phenotypes; cannabis use (r = 0.23) and other substance use (r = 0.33) were associated with subcortical volumes, and alcohol use was associated with white matter integrity (r = -0.15). Within the multivariate models, positive symptoms retained associations with the global neuroimaging (r = -0.13), the cortical thickness (r = -0.22), and the task-related activation variates (r = -0.18); negative symptoms were mostly associated with measures of subcortical volume (r = 0.23), and depression/anxiety was associated with measures of white matter integrity (r = 0.12). Conclusions and Relevance: Multivariate analyses provide a more accurate characterization of the association between brain alterations and psychosis because they enable the modeling of other key factors that influence neuroimaging phenotypes.
Authors: Alan Anticevic; Jared X Van Snellenberg; Rachel E Cohen; Grega Repovs; Erin C Dowd; Deanna M Barch Journal: Schizophr Bull Date: 2010-12-01 Impact factor: 9.306
Authors: Tyler A Lesh; Costin Tanase; Benjamin R Geib; Tara A Niendam; Jong H Yoon; Michael J Minzenberg; J Daniel Ragland; Marjorie Solomon; Cameron S Carter Journal: JAMA Psychiatry Date: 2015-03 Impact factor: 21.596
Authors: Carol A Tamminga; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Bradley Witte; David W Morris; Jeffrey Bishop; Gunvant K Thaker; John A Sweeney Journal: Am J Psychiatry Date: 2013-11 Impact factor: 18.112
Authors: Emma Sprooten; Martina Papmeyer; Annya M Smyth; Daniel Vincenz; Sibylle Honold; Guy A Conlon; T William J Moorhead; Dominic Job; Heather C Whalley; Jeremy Hall; Andrew M McIntosh; David C G Owens; Eve C Johnstone; Stephen M Lawrie Journal: Schizophr Res Date: 2013-10-10 Impact factor: 4.939
Authors: Karla L Miller; Fidel Alfaro-Almagro; Neal K Bangerter; David L Thomas; Essa Yacoub; Junqian Xu; Andreas J Bartsch; Saad Jbabdi; Stamatios N Sotiropoulos; Jesper L R Andersson; Ludovica Griffanti; Gwenaëlle Douaud; Thomas W Okell; Peter Weale; Iulius Dragonu; Steve Garratt; Sarah Hudson; Rory Collins; Mark Jenkinson; Paul M Matthews; Stephen M Smith Journal: Nat Neurosci Date: 2016-09-19 Impact factor: 24.884
Authors: Felix L Nägele; Ofer Pasternak; Lisa V Bitzan; Marius Mußmann; Jonas Rauh; Marek Kubicki; Gregor Leicht; Martha E Shenton; Amanda E Lyall; Christoph Mulert Journal: World J Biol Psychiatry Date: 2020-07-09 Impact factor: 4.132